Analysis of Complex Absorption After Multiple Dosing: Application to the Interaction Between the P-glycoprotein Substrate Talinolol and Rifampicin
- PMID: 36163409
- PMCID: PMC9780127
- DOI: 10.1007/s11095-022-03397-6
Analysis of Complex Absorption After Multiple Dosing: Application to the Interaction Between the P-glycoprotein Substrate Talinolol and Rifampicin
Abstract
Purpose: In order to clarify the effect of rifampicin on the bioavailability of the P-glycoprotein substrate talinolol, its absorption kinetics was modeled after multiple-dose oral administration of talinolol in healthy subjects.
Methods: A sum of two inverse Gaussian functions was used to calculate the time course of the input rate into the systemic circulation.
Results: The estimated rate of drug entry into the systemic circulation revealed two distinct peaks at 1 and 3.5 h after administration. Rifampicin did not affect bioavailability of talinolol, but did shift the second peak of the input function by 1.3 h to later times. Elimination clearance and one of the intercompartmental distribution clearances increased significantly under rifampicin treatment.
Conclusions: Rifampicin changes the time course of absorption rate but not the fraction absorbed of talinolol. The model suggests the existence of two intestinal absorption windows for talinolol.
Keywords: absorption kinetics; interaction; multiple dosing; rifampicin; talinolol.
© 2022. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures





Similar articles
-
Grapefruit juice enhances intestinal absorption of the P-glycoprotein substrate talinolol.Eur J Pharm Sci. 2001 Feb;12(4):361-7. doi: 10.1016/s0928-0987(00)00191-3. Eur J Pharm Sci. 2001. PMID: 11231102 Review.
-
Stereoselective disposition of talinolol in man.J Pharm Sci. 2002 Feb;91(2):303-11. doi: 10.1002/jps.10054. J Pharm Sci. 2002. PMID: 11835190
-
Induction of P-glycoprotein by rifampin increases intestinal secretion of talinolol in human beings: a new type of drug/drug interaction.Clin Pharmacol Ther. 2000 Oct;68(4):345-55. doi: 10.1067/mcp.2000.109797. Clin Pharmacol Ther. 2000. PMID: 11061574 Clinical Trial.
-
Concentration-dependent effect of naringin on intestinal absorption of beta(1)-adrenoceptor antagonist talinolol mediated by p-glycoprotein and organic anion transporting polypeptide (Oatp).Pharm Res. 2009 Mar;26(3):560-7. doi: 10.1007/s11095-008-9771-4. Epub 2008 Nov 12. Pharm Res. 2009. PMID: 19002566
-
Clinical pharmacokinetics of rifampicin.Clin Pharmacokinet. 1978 Mar-Apr;3(2):108-27. doi: 10.2165/00003088-197803020-00002. Clin Pharmacokinet. 1978. PMID: 346286 Review.
Cited by
-
Dependence of Bioavailability on Mean Absorption Time: What Does It Tell Us?AAPS J. 2023 Apr 4;25(3):36. doi: 10.1208/s12248-023-00803-8. AAPS J. 2023. PMID: 37016156
-
Distribution Clearance: Significance and Underlying Mechanisms.Pharm Res. 2024 Jul;41(7):1391-1400. doi: 10.1007/s11095-024-03738-7. Epub 2024 Jul 9. Pharm Res. 2024. PMID: 38981900 Free PMC article.
-
Relationship Between Dissolution Rate in Vitro and Absorption Rate in Vivo of Ketamine Prolonged-Release Tablets.Eur J Drug Metab Pharmacokinet. 2023 Mar;48(2):133-140. doi: 10.1007/s13318-022-00812-6. Epub 2023 Jan 16. Eur J Drug Metab Pharmacokinet. 2023. PMID: 36646846 Free PMC article.
-
The Finite Absorption Time Concept Guiding Model Informed Drug & Generics Development in Clinical Pharmacology.Pharm Res. 2025 Jun;42(6):891-906. doi: 10.1007/s11095-025-03878-4. Epub 2025 Jun 5. Pharm Res. 2025. PMID: 40473892 Free PMC article. Review.
-
Is the One-Compartment Model with First Order Absorption a Useful Approximation?Pharm Res. 2023 Sep;40(9):2147-2153. doi: 10.1007/s11095-023-03582-1. Epub 2023 Aug 18. Pharm Res. 2023. PMID: 37594592 Free PMC article.
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources